Germany· DE-A57-e23ee10bfa21b06f

Clopidogrel Aaa

A clopidogrel product containing clopidogrel, registered in Germany by Aaa-Pharma Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC B01AC04

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedClopidogrel AaaATCB01AC04REGISTER NO.DE-A57-e23ee10bfa21b0…PACKS LISTED0CHECKEDSeptember 23, 2026

Where it is registered

Clopidogrel is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AC04 (clopidogrel), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose

Clopidogrel · ATC B01AC04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clopidogrel costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.15 in Czechia to $1.20 in Norway — a ×8.2 gap.

  • 7 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Clopidogrel · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • NO Norway$1.20
  • CH Switzerland$1.04
  • IT Italy$0.48
  • FI Finland$0.43
  • IS Iceland$0.42
  • FR France$0.29
  • CZ Czechia$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Clopidogrel
Manufacturer
Aaa-Pharma Gmbh
Country
Germany (DE)
ATC code
B01AC04
ATC class
Clopidogrel
Defined daily dose
75 mg, O
Dispensing
—
Reimbursed
No
Source register
EMA Article 57 (European Union)
Last checked
September 23, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

61 interactions on record for clopidogrel.

Graded by severity as the source publishes them — 27 severe. The interaction check adds the mechanism and what to do for each pair.

  • Severity, mechanism and recommendation for each pair
  • The source and sync date on every record
  • Screen a whole medication list at once — Growth plan

Clopidogrel · interactions on record

61 records

  • 27 severe
  • 24 moderate
  • 9 minor
  • 1 info

Most severe on record

  • PiroxicamM01AC01severe
  • DiclofenacM01AB05severe
  • Ibuprofen, KombinationenM01AE51severe
  • NaproxenM01AE02severe
Mechanism and what to do, in the interaction check
Source: EPha.ch · synced 4 Jun 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8c45c4d4-92d4-4c4d-9f51-8bbfe9e840d3
GET /v1/drugs/8c45c4d4-92d4-4c4d-9f51-8bbfe9e840d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Clopidogrel",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about clopidogrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction checking is on the Growth plan. No card, nothing to install.